There's too much replication with Meller, DeBuono and Davis. Meller, in particular, has been there too long. I'm not sure what he brings to the table now that Sperzel is there. I think he should probably call it quits.
I won't talk about Davis, since she's obviously not going anywhere, but I wonder about DeBuono. She's a public health do-gooder type. That's great, but unless she's bringing in massive donor contracts (and she might), then I don't see the point.
The important aspect is . . . what new and medically important tests can we develop and use the DPP testing format that will become a $50 million market without competition. Hint - they are not all human markets. If CEMI developed a test for PRRS (Porcine Respiratory and Reproductive Syndrome) that would easily be a $50 million market because the swine industry around the world wants to eliminate this disease. Eradication can only be achieved by testing, selecting PRRS-free animals and breeding those animals. PRRS causes $billions in lost production in the US alone.
But the key to the whole enterprise is finding specific high value diagnostic targets, producing or acquiring the rights to the antigens and making monoclonal antibodies to same. That captures entire markets. While CEMI has veterinary associations, they do not listen to veterinarians. Watch the price of food and fiber skyrocket in the next 10 years. The problem of obesity will be solved when the US cannot produce enough food for the majority of its people. Fast food will go the way of the dinosaur.